Single-Port Robot-Assisted Radical Prostatectomy: Where Do We Stand?

Antonio Franco, Antony A. Pellegrino, Cosimo De Nunzio, Morgan Salkowski, Jamal C. Jackson, Lucas B. Zukowski, Enrico Checcucci, Srinivas Vourganti, Alexander K. Chow, Francesco Porpiglia, Jihad Kaouk, Simone Crivellaro, Riccardo Autorino

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations

Abstract

In 2018, the da Vinci Single Port (SP) robotic system was approved by the US Food and Drug Administration for urologic procedures. Available studies for the application of SP to prostate cancer surgery are limited. The aim of our study is to summarize the current evidence on the techniques and outcomes of SP robot-assisted radical prostatectomy (SP-RARLP) procedures. A narrative review of the literature was performed in January 2023. Preliminary results suggest that SP-RALP is safe and feasible, and it can offer comparable outcomes to the standard multiport RALP. Extraperitoneal and transvesical SP-RALP appear to be the two most promising approaches, as they offer decreased invasiveness, potentially shorter length of stay, and better pain control. Long-term, high-quality data are missing and further validation with prospective studies across different sites is required.

Original languageEnglish (US)
Pages (from-to)4301-4310
Number of pages10
JournalCurrent Oncology
Volume30
Issue number4
DOIs
StatePublished - Apr 2023
Externally publishedYes

Keywords

  • extraperitoneal
  • radical prostatectomy
  • robotic surgery
  • single port

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Single-Port Robot-Assisted Radical Prostatectomy: Where Do We Stand?'. Together they form a unique fingerprint.

Cite this